Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol

NCT02011828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Inflammation
Insulin Resistance

Interventions

DRUG: Ergocalciferol
DRUG: Placebo

Sponsor

University of Utah